Adi Lahat

6 Weizmann St, 6423906
Tel Aviv, TA 64239, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Vaccination in Immune-Mediated Intestinal Diseases: Efficacy, Safety, and Future Directions.

Vaccination in Immune-Mediated Intestinal Diseases: Efficacy, Safety, and Future Directions.

Journal: Vaccines

Published: April 27, 2026

Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.

Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.

Journal: Gastroenterology report

Published: September 18, 2025

Global guidelines on diverticular disease of the colon: the Fiesole Consensus report.

Global guidelines on diverticular disease of the colon: the Fiesole Consensus report.

Journal: Gut

Published: September 09, 2025

Accuracy of intestinal ultrasonography in the evaluation of patients with moderate-to-severe ulcerative colitis starting infliximab therapy.

Accuracy of intestinal ultrasonography in the evaluation of patients with moderate-to-severe ulcerative colitis starting infliximab therapy.

Journal: Annals of gastroenterology

Published: June 28, 2025

Fecal metabolic signals are associated with changes in microbiota and systemic metabolic pathways in Crohn's disease.

Fecal metabolic signals are associated with changes in microbiota and systemic metabolic pathways in Crohn's disease.

Journal: Scientific reports

Published: June 24, 2025

Unmasking Treatment Efficacy: A Consensus Blueprint for Steroid Stewardship in Inflammatory Bowel Disease Trials.

Unmasking Treatment Efficacy: A Consensus Blueprint for Steroid Stewardship in Inflammatory Bowel Disease Trials.

Journal: Gastroenterology

Published: June 12, 2025

Vedolizumab Achieves Pan-Enteric Mucosal Healing in Crohn's Disease: A Prospective Observational Study.

Vedolizumab Achieves Pan-Enteric Mucosal Healing in Crohn's Disease: A Prospective Observational Study.

Journal: United European gastroenterology journal

Published: June 04, 2025

Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY).

Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY).

Journal: Journal of Crohn's & colitis

Published: April 17, 2025

Fecal and Serum Metabolome in Crohn's Disease is Linked With Future Flare.

Fecal and Serum Metabolome in Crohn's Disease is Linked With Future Flare.

Journal: United European gastroenterology journal

Published: March 05, 2025

Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease.

Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease.

Journal: Clinical pharmacokinetics

Published: November 17, 2024

Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled Trial.

Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled Trial.

Journal: Gastroenterology

Published: November 07, 2024

Genetic Risk of Ankylosing Spondylitis and Second-Line Therapy Need in Crohn's Disease: A Mendelian Randomization Study.

Genetic Risk of Ankylosing Spondylitis and Second-Line Therapy Need in Crohn's Disease: A Mendelian Randomization Study.

Journal: Journal of clinical medicine

Published: November 01, 2024

Showing 1-12 of 114

Last Updated: 09/26/2026